PDB Short entry for 2HAL HEADER HYDROLASE/HYDROLASE INHIBITOR 13-JUN-06 2HAL TITLE AN EPISULFIDE CATION (THIIRANIUM RING) TRAPPED IN THE ACTIVE SITE OF TITLE 2 HAV 3C PROTEINASE INACTIVATED BY PEPTIDE-BASED KETONE INHIBITORS COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEPATITIS A PROTEASE 3C; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: 3C PROTEINASE, RESIDUES 1520-1731; COMPND 5 EC: 3.4.22.28; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: N-ACETYL-LEUCYL-PHENYLALANYL-PHENYLALANYL-GLUTAMATE- COMPND 10 FLUOROMETHYLKETONE INHIBITOR; COMPND 11 CHAIN: I; COMPND 12 SYNONYM: AC-LFFE-FMK; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HEPATITIS A VIRUS; SOURCE 3 ORGANISM_TAXID: 12092; SOURCE 4 GENE: 3C; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: D1210; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PHAV-3CEX; SOURCE 10 MOL_ID: 2; SOURCE 11 SYNTHETIC: YES KEYWDS HEPATITIS A VIRUS, 3C PROTEASE, INHIBITOR DESIGN, METHYLKETONE, KEYWDS 2 EPISULFIDE, PICORNAIN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.YIN,M.M.CHERNEY,E.M.BERGMANN,M.N.JAMES REVDAT 5 30-AUG-23 2HAL 1 REMARK SEQADV LINK REVDAT 4 13-JUL-11 2HAL 1 VERSN REVDAT 3 24-FEB-09 2HAL 1 VERSN REVDAT 2 29-AUG-06 2HAL 1 JRNL REVDAT 1 08-AUG-06 2HAL 0 JRNL AUTH J.YIN,M.M.CHERNEY,E.M.BERGMANN,J.ZHANG,C.HUITEMA, JRNL AUTH 2 H.PETTERSSON,L.D.ELTIS,J.C.VEDERAS,M.N.JAMES JRNL TITL AN EPISULFIDE CATION (THIIRANIUM RING) TRAPPED IN THE ACTIVE JRNL TITL 2 SITE OF HAV 3C PROTEINASE INACTIVATED BY PEPTIDE-BASED JRNL TITL 3 KETONE INHIBITORS. JRNL REF J.MOL.BIOL. V. 361 673 2006 JRNL REFN ISSN 0022-2836 JRNL PMID 16860823 JRNL DOI 10.1016/J.JMB.2006.06.047 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.YIN,M.M.CHERNEY,E.M.BERGMANN,M.S.LALL,R.P.JAIN, REMARK 1 AUTH 2 J.C.VEDERAS,M.N.G.JAMES REMARK 1 TITL DUAL MODES OF MODIFICATION OF HEPATITIS A VIRUS 3C PROTEASE REMARK 1 TITL 2 BY A SERINE-DERIVED BETA-LACTONE: SELECTIVE CRYSTALLIZATION REMARK 1 TITL 3 AND FORMATION OF A FUNCTIONAL CATALYTIC TRIAD IN THE ACTIVE REMARK 1 TITL 4 SITE REMARK 1 REF J.MOL.BIOL. V. 354 854 2005 REMARK 1 REFN ISSN 0022-2836 REMARK 1 PMID 16288920 REMARK 1 DOI 10.1016/J.JMB.2005.09.074 REMARK 1 REFERENCE 2 REMARK 1 AUTH E.M.BERGMANN,M.M.CHERNEY,J.MCKENDRICK,S.FRORMANN,C.LUO, REMARK 1 AUTH 2 B.A.MALCOLM,J.C.VEDERAS,M.N.JAMES REMARK 1 TITL CRYSTAL STRUCTURE OF AN INHIBITOR COMPLEX OF THE 3C REMARK 1 TITL 2 PROTEINASE FROM HEPATITIS A VIRUS (HAV) AND IMPLICATIONS FOR REMARK 1 TITL 3 THE POLYPROTEIN PROCESSING IN HAV REMARK 1 REF VIROLOGY V. 265 153 1999 REMARK 1 REFN ISSN 0042-6822 REMARK 1 PMID 10603326 REMARK 1 DOI 10.1006/VIRO.1999.9968 REMARK 1 REFERENCE 3 REMARK 1 AUTH E.M.BERGMANN,S.C.MOSIMANN,M.M.CHERNAIA,B.A.MALCOLM,M.N.JAMES REMARK 1 TITL THE REFINED CRYSTAL STRUCTURE OF THE 3C GENE PRODUCT FROM REMARK 1 TITL 2 HEPATITIS A VIRUS: SPECIFIC PROTEINASE ACTIVITY AND RNA REMARK 1 TITL 3 RECOGNITION REMARK 1 REF J.VIROL. V. 71 2436 1997 REMARK 1 REFN ISSN 0022-538X REMARK 1 PMID 9032381 REMARK 2 REMARK 2 RESOLUTION. 1.35 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.35 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 85.5 REMARK 3 NUMBER OF REFLECTIONS : 36916 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.185 REMARK 3 R VALUE (WORKING SET) : 0.184 REMARK 3 FREE R VALUE : 0.204 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1948 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.35 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.39 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1244 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 39.47 REMARK 3 BIN R VALUE (WORKING SET) : 0.2310 REMARK 3 BIN FREE R VALUE SET COUNT : 64 REMARK 3 BIN FREE R VALUE : 0.2830 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1686 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 16 REMARK 3 SOLVENT ATOMS : 435 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 17.01 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.61000 REMARK 3 B22 (A**2) : -0.11000 REMARK 3 B33 (A**2) : -0.49000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.092 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.071 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.038 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.979 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.959 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.951 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1726 ; 0.008 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2330 ; 1.210 ; 1.974 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 215 ; 6.103 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 72 ;34.093 ;24.861 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 302 ;12.473 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 7 ;14.513 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 263 ; 0.077 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1278 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 886 ; 0.206 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1195 ; 0.305 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 307 ; 0.111 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 50 ; 0.153 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 57 ; 0.122 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1097 ; 4.548 ; 8.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1729 ; 5.372 ;15.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 706 ; 5.655 ;18.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 601 ; 7.085 ;20.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 1803 ; 3.134 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): 435 ; 5.111 ; 3.000 REMARK 3 SPHERICITY; BONDED ATOMS (A**2): 1693 ; 5.289 ; 3.000 REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2HAL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-JUN-06. REMARK 100 THE DEPOSITION ID IS D_1000038136. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-JUL-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.3.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.1159 REMARK 200 MONOCHROMATOR : CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38893 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.350 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 85.3 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.06100 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 13.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.35 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.40 REMARK 200 COMPLETENESS FOR SHELL (%) : 42.4 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.28800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 2H6M REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.51 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.14 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.5% PEG 8000, 1.5% GLYCEROL, 10MM REMARK 280 TRIS-HCL, PH 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 297K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 22.29200 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 40.52600 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.12000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 40.52600 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 22.29200 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 28.12000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1490 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10090 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -11.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, I REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 THE COORDINATES OF METHYLKETONE GLUTAMATE AND EPISULFIDE REMARK 400 METHYLGLUTAMATE ARE ALTERNATE CONFORMATIONS OF THE SAME INHIBITOR. REMARK 400 IN THE METHYLKETONE GLUTAMATE CONFORMATION, THE INHIBITOR FORMS REMARK 400 ONLY ONE SINGLE COVALENT BOND (FROM ATOM C1) TO SG OF CYS172 REMARK 400 (ALTERNATE CONFORMATION B OF CYS172). IN EPISULFIDE METHYLGLUTAMATE REMARK 400 CONFORMATION, THE INHIBITOR FORMS TWO COVALENT BONDS (FROM ATOMS C1 REMARK 400 AND C, RESPECTIVELY) TO SG OF CYS172 (ALTERNATE CONFORMATION A), REMARK 400 LEADING TO THE FORMATION OF AN EPISULFIDE CATION (THIIRANIUM RING). REMARK 400 REMARK 400 THE N-ACETYL-L-LEUCYL-L-PHENYLALANYL-N-[(1S,2R)-1-(2-CARBOXYETHYL)- REMARK 400 3-FLUORO-2-HYDROXYPROPYL]-L-PHENYLALANINAMIDE IS PEPTIDE-LIKE, A REMARK 400 MEMBER OF INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: N-ACETYL-L-LEUCYL-L-PHENYLALANYL-N-[(1S,2R)-1-(2- REMARK 400 CARBOXYETHYL)-3-FLUORO-2-HYDROXYPROPYL]-L-PHENYLALANINAMIDE REMARK 400 CHAIN: I REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MET A 29 -168.18 -167.36 REMARK 500 ASP A 36 -127.61 49.80 REMARK 500 ASP A 84 -73.03 68.26 REMARK 500 ASN A 124 48.07 37.32 REMARK 500 GLN A 159 84.67 59.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BBL A 901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN I OF N-ACETYL-LEUCYL REMARK 800 -PHENYLALANYL-PHENYLALANYL-GLUTAMATE-FLUOROMETHYLKETONE INHIBITOR REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2H6M RELATED DB: PDB REMARK 900 STRUCTURE OF THE HEPATITIS A VIRUS 3C PROTEIN COMPLEXED WITH BBL REMARK 900 AND EPQ INHIBITORS REMARK 900 RELATED ID: 2H9H RELATED DB: PDB REMARK 900 STRUCTURE OF THE SAME 3C PROTEIN COMPLEXED WITH BBL AND EPQ REMARK 900 INHIBITORS REMARK 900 RELATED ID: 2A4O RELATED DB: PDB REMARK 900 STRUCTURE OF THE SAME 3C PROTEIN COMPLEXED WITH BBL INHIBITOR REMARK 900 RELATED ID: 2CXV RELATED DB: PDB REMARK 900 STRUCTURE OF HAV 3C IN COMPLEX WITH BBL AND IODO-VAL-PHE INHIBITORS REMARK 900 RELATED ID: 1HAV RELATED DB: PDB REMARK 900 HAV 3C CRYSTAL STRUCTURE REMARK 900 RELATED ID: 1QA7 RELATED DB: PDB REMARK 900 HAV 3C CRYSTAL STRUCTURE, IN COMPLEX WITH IODO-VAL-PHE DBREF 2HAL A 1 212 UNP Q81090 POLG_HAVMB 1520 1731 DBREF 2HAL I 1 6 PDB 2HAL 2HAL 1 6 SEQADV 2HAL SER A 24 UNP Q81090 CYS 1543 ENGINEERED MUTATION SEQADV 2HAL GLU I 5 PDB 2HAL GLK 5 MICROHETEROGENEITY SEQRES 1 A 212 SER THR LEU GLU ILE ALA GLY LEU VAL ARG LYS ASN LEU SEQRES 2 A 212 VAL GLN PHE GLY VAL GLY GLU LYS ASN GLY SER VAL ARG SEQRES 3 A 212 TRP VAL MET ASN ALA LEU GLY VAL LYS ASP ASP TRP LEU SEQRES 4 A 212 LEU VAL PRO SER HIS ALA TYR LYS PHE GLU LYS ASP TYR SEQRES 5 A 212 GLU MET MET GLU PHE TYR PHE ASN ARG GLY GLY THR TYR SEQRES 6 A 212 TYR SER ILE SER ALA GLY ASN VAL VAL ILE GLN SER LEU SEQRES 7 A 212 ASP VAL GLY PHE GLN ASP VAL VAL LEU MET LYS VAL PRO SEQRES 8 A 212 THR ILE PRO LYS PHE ARG ASP ILE THR GLN HIS PHE ILE SEQRES 9 A 212 LYS LYS GLY ASP VAL PRO ARG ALA LEU ASN ARG LEU ALA SEQRES 10 A 212 THR LEU VAL THR THR VAL ASN GLY THR PRO MET LEU ILE SEQRES 11 A 212 SER GLU GLY PRO LEU LYS MET GLU GLU LYS ALA THR TYR SEQRES 12 A 212 VAL HIS LYS LYS ASN ASP GLY THR THR VAL ASP LEU THR SEQRES 13 A 212 VAL ASP GLN ALA TRP ARG GLY LYS GLY GLU GLY LEU PRO SEQRES 14 A 212 GLY MET CYS GLY GLY ALA LEU VAL SER SER ASN GLN SER SEQRES 15 A 212 ILE GLN ASN ALA ILE LEU GLY ILE HIS VAL ALA GLY GLY SEQRES 16 A 212 ASN SER ILE LEU VAL ALA LYS LEU VAL THR GLN GLU MET SEQRES 17 A 212 PHE GLN ASN ILE SEQRES 1 I 6 ACE LEU PHE PHE GLK CF0 MODRES 2HAL GLK I 5 GLU HET ACE I 1 3 HET GLK I 5 9 HET CF0 I 6 2 HET BBL A 901 16 HETNAM ACE ACETYL GROUP HETNAM GLK (4S)-4-AMINO-5,5-DIHYDROXYPENTANOIC ACID HETNAM CF0 FLUOROMETHANE HETNAM BBL N-[(BENZYLOXY)CARBONYL]-L-ALANINE HETSYN CF0 FLUORO METHYL GROUP HETSYN BBL N-BENZYLOXYCARBONYL-L-SERINE-BETALACTONE FORMUL 2 ACE C2 H4 O FORMUL 2 GLK C5 H11 N O4 FORMUL 2 CF0 C H3 F FORMUL 3 BBL C11 H13 N O4 FORMUL 4 HOH *435(H2 O) HELIX 1 1 SER A 1 ASN A 12 1 12 HELIX 2 2 HIS A 44 TYR A 46 5 3 HELIX 3 3 ASP A 51 GLU A 53 5 3 HELIX 4 4 GLY A 71 VAL A 73 5 3 HELIX 5 5 ILE A 99 PHE A 103 5 5 HELIX 6 6 LYS A 105 ALA A 112 5 8 HELIX 7 7 ASN A 180 GLN A 184 5 5 HELIX 8 8 THR A 205 ILE A 212 5 8 SHEET 1 A 7 THR A 64 SER A 69 0 SHEET 2 A 7 MET A 55 ARG A 61 -1 N PHE A 57 O ILE A 68 SHEET 3 A 7 LEU A 13 GLU A 20 -1 N GLY A 19 O GLU A 56 SHEET 4 A 7 ARG A 26 LYS A 35 -1 O MET A 29 N PHE A 16 SHEET 5 A 7 TRP A 38 PRO A 42 -1 O TRP A 38 N VAL A 34 SHEET 6 A 7 VAL A 85 LYS A 89 -1 O MET A 88 N LEU A 39 SHEET 7 A 7 VAL A 74 GLN A 76 -1 N GLN A 76 O LEU A 87 SHEET 1 B 7 THR A 126 GLU A 132 0 SHEET 2 B 7 ALA A 117 VAL A 123 -1 N LEU A 119 O ILE A 130 SHEET 3 B 7 ALA A 175 SER A 178 -1 O ALA A 175 N VAL A 120 SHEET 4 B 7 ILE A 187 GLY A 195 -1 O LEU A 188 N LEU A 176 SHEET 5 B 7 ILE A 198 LEU A 203 -1 O VAL A 200 N ALA A 193 SHEET 6 B 7 THR A 152 LYS A 164 -1 N TRP A 161 O ALA A 201 SHEET 7 B 7 LYS A 136 LYS A 146 -1 N HIS A 145 O VAL A 153 LINK NE2 HIS A 102 CBZ BBL A 901 1555 1555 1.37 LINK SG ACYS A 172 C AGLK I 5 1555 1555 1.99 LINK SG BCYS A 172 C1 BCF0 I 6 1555 1555 1.82 LINK SG ACYS A 172 C1 ACF0 I 6 1555 1555 1.82 LINK C ACE I 1 N LEU I 2 1555 1555 1.33 LINK C PHE I 4 N AGLK I 5 1555 1555 1.34 LINK C AGLK I 5 C1 ACF0 I 6 1555 1555 1.53 LINK C BGLU I 5 C1 BCF0 I 6 1555 1555 1.52 SITE 1 AC1 12 ALA A 6 LEU A 8 ARG A 10 ARG A 97 SITE 2 AC1 12 HIS A 102 PRO A 127 MET A 128 LEU A 129 SITE 3 AC1 12 HOH A1017 HOH A1035 HOH A1108 HOH A1291 SITE 1 AC2 20 GLU A 139 VAL A 144 HIS A 145 LYS A 146 SITE 2 AC2 20 ARG A 162 GLY A 167 LEU A 168 PRO A 169 SITE 3 AC2 20 GLY A 170 MET A 171 CYS A 172 ALA A 193 SITE 4 AC2 20 GLY A 194 GLY A 195 ASN A 196 ILE A 198 SITE 5 AC2 20 VAL A 200 HOH A 973 HOH I 72 HOH I 301 CRYST1 44.584 56.240 81.052 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022430 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017781 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012338 0.00000